mizoribine has been researched along with Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jakovac, H | 1 |
| Doi, S; Doi, T; Kohno, N; Masaki, T; Nakashima, A; Ueno, T; Yokoyama, Y | 1 |
| Katayama, A; Makino, H; Matsumoto, Y; Nasu, Y; Otsuka, F; Tanabe, K; Tsukamoto, N; Yamanaka, R | 1 |
3 other study(ies) available for mizoribine and Hypertension
| Article | Year |
|---|---|
COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome?
Topics: Animals; Betacoronavirus; Chaperonin 60; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Host-Pathogen Interactions; Humans; Hypertension; Immunosuppressive Agents; Inflammation Mediators; Pandemics; Pneumonia, Viral; Prognosis; Ribonucleosides; SARS-CoV-2; Signal Transduction | 2020 |
Mizoribine ameliorates renal injury and hypertension along with the attenuation of renal caspase-1 expression in aldosterone-salt-treated rats.
Topics: Aldosterone; Animals; Blood Pressure; Caspase 1; DNA Nucleotidylexotransferase; Epithelial Sodium Channels; Fibrosis; Hypertension; Inflammation; Kidney; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Ribonucleosides; Salts; Sodium Chloride | 2014 |
Unexpected occurrence of adrenal Cushing's syndrome in a patient with systemic lupus erythematosus.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Angiomyolipoma; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cushing Syndrome; Drug Therapy, Combination; Female; Humans; Hypertension; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Nifedipine; Prednisolone; Ribonucleosides; Spironolactone; Tetrazoles | 2011 |